|
Response to: HCV Viremic Donors With Hepatic Bridging Fibrosis: Are We Ready
To Use Their Livers in The Era of Direct-Acting Antivirals?
Levitsky J, Formica RN.
Am J Transplant. 2017 Aug
31
Abstract
Regression of liver fibrosis over a 24-week period after completing
direct-acting antiviral therapy in patients with chronic hepatitis C receiving
care within the national hepatitis C elimination program in Georgia: results of
hepatology clinic HEPA experience.
Dolmazashvili E, Abutidze A, Chkhartishvili N,
et al
Eur
J Gastroenterol Hepatol.
2017 Aug 29.
Abstract
Sustained virological response by direct antiviral agents in
HCV leads to an early and significant improvement of liver fibrosis.
Persico M, Rosato V, Aglitti A, et
al
Antivir Ther.
2017 Aug 11.
Abstract
MAIT-cell frequency and function in blood and liver of HCV mono- and HCV/HIV
co-infected patients with advanced fibrosis. [Tje Netherlands}
Beudeker BJB, van Oord GW, Arends JE,
Liver
Int. 2017 Aug 9
Abstract
HCV Viremic Donors With Hepatic Bridging Fibrosis: Are We Ready To Use Their
Livers in The Era of Direct-Acting Antivirals?
Martini S, David E, Tandoi F,
et al
Am J
Transplant. 2017 Jul 25.
Abstract
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse
to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice.
López JJ, Pérez-Àlvarez N, Rodríguez RV,. et al
J Ultrasound Med. 2017 Jul 17
Abstract
APRI test and hyaluronic acid as non-invasive diagnostic
tools for post HCV liver fibrosis: Systematic review and meta-analysis.
El Serafy MA, Kassem AM, et al
Arab J Gastroenterol.
2017 Jun 1.
Abstract
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic
hepatitis C patients.
Liu CH, Liu CJ, Hong CM,
et
al
J
Gastroenterol Hepatol.
2017 May 26.
Abstract |
Stage of
liver fibrosis in patients with congenital bleeding disorders and infected with
hepatitis C virus.
Kucharska M, Zaleska-Dorobisz U,
et al
Pol Arch
Intern Med. 2017 May 22.
Abstract
FULL-TEXT ARTICLE
Concordance of
non-invasive mechanical and serum tests for liver fibrosis evaluation in
chronic hepatitis C.
Paranaguá-Vezozzo DC, Andrade A, Mazo DF, et al
World J Hepatol.
2017 Mar 18;9(8):436-442. d
.
Paper
Assessment of liver fibrosis with acoustic radiation
force impulse imaging versus liver histology in patients with chronic hepatitis
C: a pilot study.
Kohla MAS, Abbasy M, Abozeid M,
Eur J Gastroenterol Hepatol.
2017 May 3.
Abstract
The proportion of different IL-17-producing T cell subsets is associated
with liver fibrosis in chronic hepatitis C.
Cachem FC, Dias AS, Monteiro C,
Immunology.
2017 Jan 31.
Abstract
The path to cancer, and back: Immune modulation during
hepatitis C virus infection, progression to fibrosis and cancer, and
unexpected roles of new antivirals.
Debes JD, de Knegt RJ, Boonstra A.
Transplantation. 2016 Dec 30.
Abstract
FULL-TEXT ARTICLE
Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using
HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
Puigvehí
M, Hernández J, Broquetas T, .et al
PLoS One. 2016 Dec
16;11(12):e0164883.
Paper
Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C
virus-infected patients: angiogenic fibrogenic link.
Toson EA, Shiha GE, El-Mezayen HA,
et al
Eur J Gastroenterol Hepatol.
2016 Dec 7.
Abstract
Liver fibrosis indices for identifying patients at low risk of developing
hepatocellular carcinoma after eradication of HCV.
Toyoda H, Tada T, Tachi Y, et
al
Antivir Ther.
2016 Sep 2
Abstract
Viral Eradication reduces all-Cause Mortality, Including non-Liver-Related
Disease, in Patients With Progressive Hepatitis C Virus-Related Fibrose.
Tada T, Kumada T, Toyoda H,
J Gastroenterol Hepatol.
2016 Aug 30. .
Abstract
The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United
States.
Klevens RM, Canary L, Huang X,
et al
C
lin Infect Dis. 2016
Aug 9
Abstract
Fibrosis Progression in Patients with Chronic Hepatitis C Virus
Infection.
Zeremski
M, Dimova RB, Pillardy J,
et al
J
Infect Dis. 2016
Aug 2.
Abstract
European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression among
HCV and HIV/HCV Coinfected Patients from Northwest Spain.
Tabernilla A, Rego-Pérez I, Grandal M, et al
J Acquir Immune Defic Syndr.
2016 May 30.
Abstract |
Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients:
Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue
Inhibitors TIMPs and Effect of HCV Protease Inhibitors.
Latronico T, Mascia C, Pati I, et
al
Int J Mol Sci. 2016 Mar
26;17(4). pii: E455
Abstract
Real-world medical costs of antiviral therapy among patients with chronic
HCV infection and advanced hepatic fibrosis.
Maan R, Zaim R, van der Meer AJ, Feld JJ, et al|
J Gastroenterol Hepatol.
2016 Mar 18.
Abstract
|
Levels of Schistosoma mansoni Circulating Antigen in Chronic
Hepatitis C Patients with Different Stages of Liver Fibrosis.
Attallah AM, El-Far
M, Omran MM,
et al
J Immunoassay Immunochem. 2016 Jan 8.
Abstract
Biochemical non-invasive assessment of liver fibrosis
cannot replace biopsy in HIV-HCV coinfected patients.
Kliemann DA, Wolff FH, Tovo CV,
et al
Ann Hepatol. 2015 Jan-2016
Feb;15(1):27-32.
Abstract
Lack of Siglec-7 expression identifies a dysfunctional
natural killer cell subset associated with liver inflammation and fibrosis
in chronic HCV infection.
Varchetta S, Mele D, Lombardi A, et al
Gut.
2015 Dec 16.
Abstract
Improvement of platelets after SVR among patients with
chronic HCV infection and advanced hepatic fibrosis.
van der Meer AJ,
Maan R, Veldt BJ, et al
J Gastroenterol Hepatol. 2015 Dec 8.
Abstract
Relationship of hepatic fibrosis, cirrhosis, and mortality
with cholecystectomy in patients with hepatitis C virus infection.
Martin DJ, Weideman R, Crook T,
Brown G.
Eur J Gastroenterol Hepatol.
2015 Nov 12..
Abstract
FULL-TEXT ARTICLE
Impact of liver cirrhosis due to chronic hepatitis C viral infection
on the outcome of ovarian cancer: a prospective study.
Refky B, Kotb S, Fady T ,et
al
BMC Cancer.
2015 Oct 21;15(1):754.
Paper |
FULL-TEXT ARTICLE
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related
Rapid Fibrosis Progression and Identify Patients Who Require Urgent
Antiviral Treatment with New Regimens
Tamaki N, Kurosaki M, Higuchi M,
et al
PLoS One. 2015 Sep
9;10(9):e0137351.
Paper
Insulin
Resistance is Associated With Significant Liver Fibrosis in Chronic
Hepatitis C Patients: A Systemic Review and Meta-Analysis.
Patel S, Jinjuvadia R, Patel R, Liangpunsakul S.
J Clin Gastroenterol. 2015
Aug 19
Abstract
FULL-TEXT ARTICLE
Infection
of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of
Liver Fibrosis in Hepatitis C.
Aoudjehane L, Bisch G, Scatton O, et al
PLoS One.
2015 Jul 27;10(7):e0134141.
Paper
FULL-TEXT ARTICLE
Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with
Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
Tachi Y, Hirai T, Toyoda H, et al
PLoS One. 2015 Jul
27;10(7):e0133515
Paper
Impact of Fibrosis Progression on Clinical Outcome in
Patients Treated for Post- Transplant Hepatitis C Recurrence.
Lens S, Mariño Z, Forns X.
Liver Int.
2015 Jul 18
Abstract
Current drugs in early development for treating hepatitis C
virus-related hepatic fibrosis.
Jaroszewicz J,
Flisiak-Jackiewicz M, et al
Expert Opin Investig Drugs.
2015 Jun 30:1-11.
Abstract
Effect of addition of statins to antiviral therapy in HCV
infected persons: Results from ERCHIVES.
Butt AA, Yan P, Bonilla H, et al
Hepatology.
2015 Apr 6.
Abstract
Liver fibrosis, microbial translocation and immune activation
markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P, Cima S, Corbella M, et al
Dig Liver Dis.
2014 Nov 29
Abstract
FULL-TEXT ARTICLE
Clinicobiochemical prediction of biopsy-proven cases of severe hepatic
fibrosis in patients with chronic hepatitis C infection.
Jin YJ, Shim JH, Kim GA, et al
BMJ Open. 2014 Nov
27;4(11):e006255.
Paper
Liver fibrosis progression despite HCV cure with antiviral
therapy in HIV-HCV-coinfected patients.
Labarga P, Fernandez-Montero JV,
et al
Antivir Ther.
2014 Nov 5.
Abstract
Association between serum vitamin D and severity of liver fibrosis in
chronic hepatitis C patients: a systematic meta-analysis
Luo YQ, Wu XX, Ling ZX, et al
J Zhejiang Univ Sci B.
2014 Oct;15(10):900-6
Abstract
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis
progression in patients with chronic hepatitis C
Nielsen MJ, Veidal SS, Karsdal MA, et al
Liver Int. 2014 Oct 11.
Abstract
Impact of common risk factors of fibrosis progression in chronic hepatitis
C.
Rüeger S, Bochud PY, Dufour JF, et al
Gut. 2014 Sep 11. pii: gutjnl-2014-306997.
Abstract
Aspirin may reduce liver fibrosis progression: Evidence from
a multicenter retrospective study of recurrent hepatitis C after liver
transplantation.
Poujol-Robert A, Boëlle PY, Conti F, et al
Clin Res Hepatol Gastroenterol.
2014 Aug 14.
Abstract
FULL-TEXT
ARTICLE
Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as
Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV
Coinfected Patients.
Corchado S, López-Cortés LF, Rivero-Juárez A,
et al
PLoS One. 2014 Jul
11;9(7):e101760.
Paper
Treatment
failure may lead to accelerated fibrosis progression in patients with chronic
hepatitis C.
Baran
B, Gulluoglu M, Soyer OM, et al
J
Viral Hepat. 2014
Feb;21(2):111-20.
Abstract
Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline
and oxidative stress biomarkers.
Gabr SA, Alghadir AH.
Indian J Virol.
2014 Jan;25(1):91-100.
Abstract
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids
versus tacrolimus: randomised trial long term outcomes.
Manousou P, Cholongitas E, Samonakis D, Tsochatzis E, et
al
Gut. 2013 Oct 16
Abstract
Liver fibrosis progression at autopsy in injecting drug users
infected by hepatitis C: A longitudinal long-term cohort study
Kielland KB, Delaveris GJ, Rogde S, et al
J Hepatol. 2013 Oct 1.
Abstract
Factors influencing liver fibrosis and necroinflammation in
HIV/HCV coinfection and HCV monoinfection.
Sagnelli C, Uberti-Foppa C,
Pasquale G, et al
Infection.
2013 Jul 10.
Abstract
Ultrasound Elastography for Fibrosis Surveillance
Is Cost Effective in Patients with Chronic Hepatitis C Virus in the UK.
Canavan C, Eisenburg J, Meng L, et al
Dig Dis Sci.
2013 May 30|
Abstract
The association of non-O blood group and severity
of liver fibrosis in patients with chronic hepatitis C infection
Shavakhi A, Hajalikhani
M, Minakari M,
et al
J Res Med Sci. 2012
May;17(5):466-9
Abstract
Pathogenesis of Accelerated Fibrosis in HIV/HCV
Co-infection.
Lin W, Weinberg EM, Chung RT.J
J Infect Dis. 2013
Mar;207 Suppl 1:S13-8
Abstract |
Patients with HCV and F1 and F2 fibrosis stage:
treat now or wait?
Shiffman ML,
Benhamou Y
Liver Int. 2013
Feb;33 Suppl 1:105-10. .
Abstract |
Biomarkers of fibrosis and impaired liver function in
chronic hepatitis C: how well
do they predict clinical outcomes?
Peters L, Rockstroh JK.
Curr Opin HIV
AIDS.
2010 Nov;5(6):517-23.
Abstract |
Impact of HIV on liver fibrosis in men with
hepatitis C infection and haemophilia.
Ragni MV, Moore CG, Soadwa K, et al
Haemophilia.
2010 Aug 16.
Abstract |
HCV
Clinical Variants
Documents
identified with this icon are in Portable Document Format (PDF) and require
the
Adobe Acrobat
Reader|